机译:靶向树突状细胞的整合缺陷型慢病毒载体提供的疫苗可诱导强抗原特异性免疫。
antigens; biotechnology; CD8+ lymphocytes; dendritic cells; gene therapy; genes; genetic engineering; genetic vectors; immune response; immunity; immunization; immunotherapy; laboratory animals; neoplasm antigens; neoplasms; transduction; vaccination; vaccines; viral proteins; Human immunodeficiency virus 1; Lentivirus; mice; Sindbis virus; human immunodeficiency viruses; Lentivirus; Orthoretrovirinae; Retroviridae; RNA Reverse Transcribing Viruses; viruses; Muridae; rodents; mammals; vertebrates; Chordata; animals; small mammals; eukaryotes; Alphavirus; Togaviridae; posit; ive-sense ssRNA viruses; ssRNA viruses; RNA viruses; antigenicity; cancers; CD8+ cells; cloning vectors; genetic manipulation; immune sensitization; immunity reactions; immunogens; immunological reactions; T8 lymphocytes.;
机译:靶向树突状细胞的整合缺陷型慢病毒载体提供的疫苗可诱导强抗原特异性免疫。
机译:LV305,一种编码树突状细胞靶向整合缺陷型ZVex TM sup>的慢病毒载体,编码NY-ESO-1,可诱导有效的抗肿瘤免疫应答
机译:TLR4激动剂与树突状细胞定向慢病毒载体协同作用TLR4激动剂与树突状细胞定向慢病毒载体协同作用以诱导抗原特异性免疫应答
机译:靶向树突细胞并诱导强抗抗体或CTL响应的基于合成肽的疫苗
机译:靶向CD40的腺病毒载体可增强树突状细胞的抗原特异性疫苗接种。
机译:通过整合缺陷的慢病毒载体提供疫苗靶向树突细胞诱导强烈的抗原特异性免疫力
机译:通过整合缺陷的慢病毒载体提供疫苗靶向树突细胞诱导强烈的抗原特异性免疫力